Staff Services Student Enterprise

Clinical sciences

Clinical Sciences at the University of Edinburgh has an international reputation for research excellence and innovation.

Clinical Sciences is a Deanery within the Edinburgh Medical School, and is home to the British Heart Foundation Centre for Cardiovascular Science, the Medical Research Council (MRC) Centre for Inflammation Research, the MRC Centre for Regenerative Medicine, the MRC Centre for Reproductive Health, the Centre for Clinical Brain Sciences and the Edinburgh Dental Institute.

Clinical Sciences boasts world-class research, state-of-the-art facilities, MRC-funded centres, all major imaging technologies and close collaboration with NHS hospitals, and provides clinical trials support and co-location of research centres to enable interdisciplinarity, as well as commercialisation training and opportunities.

Key areas of expertise

Reproductive Health

The MRC Centre for Reproductive Health brings together scientists with expertise in reproductive biology, stem cells, inflammation, development, hormonal disease and imaging to research conditions that affect the reproductive ability and the health of men and women.

Inflammation Research

The Centre for Inflammation Research promotes the prevention, diagnosis, and treatment of inflammatory diseases through the interdisciplinary study of the initiation, regulation and resolution of inflammatory responses. Within a grouping of over 120 researchers, there is a strong clinical influence based around respiratory medicine, renal medicine and histopathology.

Clinical Brain Sciences

The Centre for Clinical Brain Sciences (CCBS) undertakes fundamental and clinical research into major neurological disorders. CCBS investigators from across groups, Schools and Colleges study the causes, consequences and treatment of major brain disorders, as well as playing a key role in translating research findings into benefits for patients.

Cardiovascular Science

The Centre for Cardiovascular Science is a world-leading centre of excellence that integrates discovery, translational and clinical cardiovascular research to transform the diagnosis, treatment and management of people with heart and circulatory diseases. The research centre receives major support from the Wellcome Trust, the British Heart Foundation, and the Medical Research Council.

Regenerative Medicine

The Centre for Regenerative Medicine brings together world-leading basic stem cell research with established clinical excellence to deliver a "bench-to-bedside" approach aimed at developing new treatments for major diseases including cancer, diabetes, degenerative diseases such as multiple sclerosis and Parkinson's disease, and liver failure.

Dental

Edinburgh Dental Institute provides academically rigorous programmes within its excellent clinical and teaching facilities. The Institute has strong cooperation and collaboration links between the University of Edinburgh, NHS Lothian, NHS Education for Scotland and the Royal College of Surgeons of Edinburgh.

Find out more

Dr Jane Redford

Interim Business Development Manager
College of Medicine and Veterinary Medicine
Edinburgh Neuroscience, Infection Medicine
Edinburgh BioQuarter

28 Mar 2024
News  
New tool detects signs of motor neuron disease before symptoms begin
Clinical sciences
Medical technologies
Neuroscience
29 Feb 2024
Opinion  
Phenotyping endometriosis: how big data can close the knowledge gap
Bench to Bedside
Clinical sciences
26 Jan 2024
News  
Scotland's AI and life sciences showcased in Edinburgh BioQuarter visit
Biotechnology
Clinical sciences
Data, AI & robotics
08 Jan 2024
News  
Prof Quentin Anstee of Newcastle University with a lab technician in a lab
£30M ADVANCE study paves the way for new liver cirrhosis treatments
Bench to Bedside
Biotechnology
Clinical sciences
13 Nov 2023
News  
New cell therapy shows progress in treating advanced liver disease
Biotechnology
Clinical sciences
Tissue regeneration and repair
11 Jul 2023
News  
eoSurgical: simulation spinout is acquired by medical training company
Clinical sciences
Medical technologies
Startups and spinouts
29 Jun 2023
News  
NEURii: New global collaboration to transform dementia care
Clinical sciences
Data, AI & robotics
Neuroscience
12 Jun 2023
Opinion  
Scotland's life sciences need support to join the world’s best
Bench to Bedside
Clinical sciences
Commercialisation
12 Jun 2023
Opinion  
Dr Prakash Ramachandran profile picture
Scotland in pole position to translate liver disease research
Bench to Bedside
Clinical sciences
Therapeutics
11 May 2023
News  
AI in heart attack diagnosis could reduce pressure on emergency departments
Clinical sciences
Data, AI & robotics
Medical technologies
16 Aug 2022
News  
Graphene-based test to revolutionise liver transplants
Clinical sciences
Tissue regeneration and repair
01 Jun 2022
News  
BioCaptiva: investment to transform biopsy testing
Bench to Bedside
Clinical sciences
Genetics and cancer
Investment
Startups and spinouts
Case Study  
Collaborative research in predictive biomarkers
Biotechnology
Clinical sciences
Case Study  
BioCaptiva: new biopsy technology detects cancer early
Bench to Bedside
Clinical sciences
Genetics and cancer
Startups and spinouts
Case Study  
Pheno Therapeutics
Clinical sciences
Neuroscience
Startups and spinouts
Therapeutics
Tissue regeneration and repair
Case Study  
Invizius - H-Guard against inflammation
Clinical sciences
Medical technologies
Startups and spinouts
Therapeutics
Case Study  
Working with big pharma to find new liver treatments
Clinical sciences
Tissue regeneration and repair
16 Apr 2021
Opinion  
Liver disease: tackling a global challenge
Clinical sciences
Data, AI & robotics
Technology  
Aptamers for the early detection and monitoring of neurodegenerative diseases
A novel approach for ALS and FTD using single-stranded RNA aptamers to selectively identify TDP-43 protein aggregates
Clinical sciences
Medical technologies
Neuroscience
Technology  
In vitro culture of oocytes
Improved fertility and fertility preservation
Clinical sciences
Therapeutics
Technology  
Cell model of Parkinson’s disease
A valuable experimental system to identify compounds that reduce levels and aggregation of α-synuclein and investigate the mechanistic basis of neurodegeneration.
Clinical sciences
Neuroscience
Therapeutics
Technology  
Engineered reprogramming factors for iPSC generation
A series of engineered molecules that retain a highly specific ability to reprogram adult or fully differentiated cells into pluripotent stem cells only.
Biotechnology
Clinical sciences
Technology  
Vascular Pathologies Treatment
Therapeutic target for treating vascular pathologies.
Clinical sciences
Therapeutics